| | | | | |
PLMK Plum Acquisition Corp. IV Class A Ordinary Shares | €9,1440 | -0,05% | €221,46M | €16,67K | |
DMAA Drugs Made In America Acquisition Corp. Ordinary Shares | €9,1182 | +0,00% | €221,36M | €87,65 | |
ERC Allspring Multi-Sector Income Fund | €7,8377 | +0,55% | €221,32M | €21,80K | |
GLO Clough Global Opportunities Fund | €5,1779 | -0,17% | €221,25M | €7,37K | |
NTWO Newbury Street II Acquisition Corp Class A Ordinary Shares | €9,1698 | +0,28% | €221,14M | €106,56 | |
TRGS TRG Latin America Acquisitions Corp. Class A Ordinary Shares | €8,4900 | -0,01% | €220,66M | €14,02K | |
CPZ Calamos Long/Short Equity & Dynamic Income Trust Common Stock | €11,0510 | +0,07% | €220,17M | €16,75K | |
| €3,4634 | +3,87% | €219,91M | €40,84K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,4825 | +3,29% | €219,72M | €118,85K | |
PNNT Pennant Investment Corp | €3,4419 | +2,96% | €219,41M | €155,41K | |
VNME Vendome Acquisition Corporation I Class A Ordinary Shares | €8,7702 | -0,05% | €219,14M | €199,38 | |
NUW Nuveen AMT-Free Municipal Value Fund | €12,0574 | +0,50% | €219,06M | €21,02K | |
| €33,8260 | +3,25% | €219,06M | €1,14K | |
DSP Viant Technology Inc. Class A Common Stock | €10,7666 | +3,54% | €218,86M | €27,41K | |
| €25,0524 | +2,07% | €218,76M | €8,93K | |
